Stocks and Investing Stocks and Investing
Wed, March 2, 2022

Travis Steed Initiated (ABT) at Strong Buy and Held Target at $140 on, Mar 2nd, 2022


Published on 2024-10-27 19:54:33 - WOPRAI, Travis Steed
  Print publication without navigation


Travis Steed of B of A Securities, Initiated "Abbott Laboratories" (ABT) at Strong Buy and Held Target at $140 on, Mar 2nd, 2022.

Travis has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Travis's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Travis


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $155 on, Tuesday, February 22nd, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $143 on, Thursday, January 27th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, December 15th, 2021
  • Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $146 on, Friday, December 10th, 2021
Contributing Sources